Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
New Trial Ordered in Androgel Lawsuit Over Fraudulent Misrepresentation December 28, 2017 Irvin Jackson Add Your Comments The U.S. District Judge presiding over thousands of federal testosterone drug lawsuits has ordered a new trial for the first Androgel bellwether case, after an unusual verdict where the jury ordered the drug makers to pay $150 million in punitive damages, but awarded the plaintiff no compensatory damages. The Androgel verdict came in July 2017, involving a lawsuit filed by Jesse Mitchell, who suffered a heart attack that was allegedly caused by side effects of the popular testosterone replacement therapy. The case was part of a series of early trial dates scheduled to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout more than 6,500 Androgel lawsuits, Axiron lawsuits, Testim lawsuits and other claims brought against the makers of testosterone drugs in the federal court system. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION At the conclusion of the two-week trial, the jury found in favor of the plaintiff on the issue of fraudulent misrepresentation, which required that Mitchell prove that he was damaged as a direct result of his or his doctor’s reliance on the representation made by the drug’s manufacturer, AbbVie. However, the jury elected to award no economic damages for medical expenses or non-economic damages for pain and suffering. Despite the decision not to award any compensatory damages, the jury did indicate that AbbVie should pay $150 million in punitive damages, which were designed to punish the drug makers for their actions surrounding the marketing and sale of the blockbuster treatment. Given similar questions of fact and law raised by each plaintiff in the testosterone drug litigation, the cases have been centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois for coordinated discovery and management, as part of a federal multidistrict litigation (MDL). Both sides have challenged the verdict in post-trial motions, and Judge Kennelly issued a court order (PDF) last week, indicating that a new trial will be held only on the fraudulent misrepresentation claims. In the order, Judge Kennelly noted that both parties tried to avoid a new trial by arguing that the aspects of the jury’s decision that favored them were the “true” goals of the jury. However, he determined that both sides’ arguments were unconvincing, resulting in the need for a new trial, which is now set to begin on March 5, 2018. “Just as the Court may not give priority to the jury’s finding that Mitchell was damaged for purposes of the fraudulent misrepresentation claim, the Court may not, as AbbVie proposes, treat the award of zero compensatory damages as the jury’s ‘authentic’ finding that negates the liability verdict,” he wrote. “The irreconcilable conflict between the jury’s finding of liability on the fraudulent misrepresentation claim and award of zero compensatory damages requires a new trial on this claim.” In addition to the retrial of the Mitchell case, a number of other bellwether trials are set to begin against AbbVie and other drug makers over the next year. Earlier this month, the court announced that Eli Lilly had entered into an Axiron settlement agreement to resolve all of the testosterone claims against the company for an undisclosed amount. Although the outcomes of these bellwether trials are not binding on other plaintiffs, they are being closely watched by parties involved, as they may influence eventual negotiations to reach testosterone drug settlements, which would avoid the need for thousands of individual cases to be set for trial in courts nationwide over the coming years. Tags: AbbVie, Actavis, AndroGel, Axiron, Eli Lilly, Heart Attack, Stroke, Testosterone, Testosterone Gel Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis (Posted: yesterday) The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns (08/06/2025)Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries (07/29/2025)Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators (07/15/2025) BioZorb Marker Lawsuit Clears Hurdle To Reach Trial in January 2026 (Posted: yesterday) A federal judge has denied a motion by Hologic to dismiss two BioZorb marker lawsuits scheduled for early bellwether trials. MORE ABOUT: BIOZORB LAWSUITNearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (08/11/2025)Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025) Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (Posted: 2 days ago) A tabletop fire pit lawsuit claims a Texas woman’s daughter was set on fire during a family gathering by an unexpected jet of flame from a Colsen fire pit that was later recalled due to burn injury risks. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAlcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis (Posted: yesterday) The makers of GLP-1 drugs, Novo Nordisk and Eli Lilly, face another lawsuit claiming they failed to adequately warn consumers about the risks of gastroparesis injuries. MORE ABOUT: OZEMPIC LAWSUITGLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns (08/06/2025)Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries (07/29/2025)Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators (07/15/2025)
BioZorb Marker Lawsuit Clears Hurdle To Reach Trial in January 2026 (Posted: yesterday) A federal judge has denied a motion by Hologic to dismiss two BioZorb marker lawsuits scheduled for early bellwether trials. MORE ABOUT: BIOZORB LAWSUITNearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker (08/11/2025)Failed BioZorb Tissue Marker to Require Surgical Removal, Lawsuit Claims (08/04/2025)Problems With BioZorb Tissue Markers Not Adequately Disclosed by Manufacturer: Lawsuit (07/28/2025)
Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (Posted: 2 days ago) A tabletop fire pit lawsuit claims a Texas woman’s daughter was set on fire during a family gathering by an unexpected jet of flame from a Colsen fire pit that was later recalled due to burn injury risks. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAlcohol Fire Pit Recall Lawsuits Are Being Filed Over Severe Burn Injuries and Fatalities (08/07/2025)